A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005

Slides:



Advertisements
Similar presentations
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Advertisements

MRSA Found in U.S. Wastewater Treatment Plants.  MRSA is a type of staph bacteria that is resistant to certain antibiotics called beta-lactams (Centers.
PREDICTORS OF DIABETIC WOUND HEALING BY RACIAL/ETHNIC CATEGORIES Ranjita Misra 1, Lynn Lambert 2, David Vera 3, Ashley Mangaraj 3, Suchin R Khanna 3, Chandan.
Antimicrobial Susceptibility Testing – Part II
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
. Nosocomial Antibiotic Resistant Organisms Copyright © Texas Education Agency, All rights reserved.
Catheter-Associated Bloodstream Infections Based on Infectious Disease Society of America guidelines Clinical Infectious Diseases 2001;32: Rey.
Methicillin-resistant Staphylococcus aureus in Loja Province, Ecuador Student Researcher: Sarah Hof Faculty Researcher: Daniel Herman, PhD Department of.
Methicillin Resistant Staphylococcus aureus Exposure Assessment in a Burn Center Environment Cassandra Andrade, Space Grant Intern Kelly Reynolds, Ph.D.,
SS-32 To Be or Not To Be: The Dilemma of Suicide in America.
Community-acquired methicillin-resistant Staph. aureus (CA-MRSA): Amarillo experience Infectious Disease Epidemiology Work Group Texas Department of State.
A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005 By Samuel F. Barker, MT School of Rural Public Health Texas A&M Health Science Center.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Methicillin-Resistant Staphylococcus Aureus (MRSA)
Cheryl Meddles-Torres, DNP, RN, FNP-C Shuang Hu
Center for Drug Evaluation and Research March 6, 2005 Bacteremia and Endocarditis: Products and Guidance Janice Soreth, MD Director Division of Anti-Infective.
Gastric Cancers in Texas: Are Nitrates the Problem?
Life and Times of: Methicillin Resistant Staphylococcus Aureus (MRSA) Group 3.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
The Geography of Viral Hepatitis C In Texas, Mara Hedrich
1 A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital DIABETES Care; Aug 2006; 29,8 : FM R1 임혜원.
Methicillin-resistant Staphylococcus aureus (MRSA) By: Raigan Chambers.
Outcomes of Carbapenem-Resistant K. pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies Gopi Patel, MD; Shirish Huprikar, MD;
Pharmacy in Public Health: Describing Populations Course, date, etc. info.
Pattern of Hospital-Acquired Pneumonia in Intensive Care Unit of Suez Canal University Hospital By Nermine El-Maraghy Associate Professor of Medical Microbiology.
Methicillin-resistant Staphylococcus Aureus
MRSA Methicillin-resistant Staphylococcus Aureus
Nosocomial Antibiotic Resistant Organisms
S. aureus subtypes based on Methicillin resistance
Antibiotic-resistant Bacteria
Antibiotic Resistance
The Laboratory diagnosis and susceptibility testing of meticilline-resistant staphylococcus aureus By: Maj Anthere Murangwa, MSC Medical Microbiologist.
MRSA Methicillin Resistant Staphylococcus Aureus
Alison Keyser Metobo, MPH +
Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Antibacterial Drugs General Terminology Mindy Valenti
Copyright © 2008 American Medical Association. All rights reserved.
Diseases caused by Staph. aureus
MRSA: Implications in Sports Medicine
hospitalized with spontaneous bacterial peritonitis
Antibiotics sensitivity of microorganism causing nosocomial infections
HAI August 30, 2017.
HAI January 24, 2018.
Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood.
HAI Sept. 25, 2017.
Hospital Antibiotic Stewardship Programs
Care of Patients with Infection
Trends in Pneumonia Hospitalizations in Hennepin County, Minnesota,  
Clinical impact of antibiotic-resistant Gram-positive pathogens
Empirical antibiotic treatment algorithm for hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP). Empirical antibiotic treatment algorithm.
Ayman A. Hussein et al. JACEP 2016;2:
وضعیت موجود مرگ و میر و علل مرگ غیر مادری در افراد سال کارشناس اداره سلامت میانسالان معصومه آرشین چی همدان 27 و 28 تیرماه 1396.
Treatment of staphylococcal infections with cyclic lipopeptides
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
MRSA=Methicillin resistant Staphylococcus aureus
Lacie Shea, Gracyn Fuller
Prevention and Control of MRSA vs. VRE
Can β-lactams be re-engineered to beat MRSA?
A.W. Karchmer  Clinical Microbiology and Infection 
P.M. Hawkey  Clinical Microbiology and Infection 
Lorna Perez, Ethan Gough
J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T
Alzheimer’s Disease in New Mexico
J. Segreti  Clinical Microbiology and Infection 
Effect of detergent and disinfectant cleaning on total Staphylococcus aureus (methicillin-susceptible S. aureus [MSSA] and methicillin-resistant S. aureus.
Recent Incidences and Trends of the Top Cancers in Northeast Tennessee Appalachian Region Adekunle Oke1, Sylvester Orimaye2, Ndukwe Kalu1, Dr. Faustine.
Presentation transcript:

A GIS Approach to Staphylococcus Associated Mortality in Texas in 2005 By Samuel F. Barker, MT School of Rural Public Health Texas A&M Health Science Center Refer all questions to: Marilyn.Felkner@dshs.state.tx.us

Updates and Assumptions Oxacillin, Nafcillin, and Methicillin were treated equally to establish methicillin resistance. By definition, MRSA is genetically resistant to: Betalactams Cephalosporins Carbapenems Intermediate resistance was treated as resistant based on clinical treatment protocols.

Texas Death Cohort 2005 155,924 deaths on record 439 records listed Staphylococcus sp. as a contributing cause 223 records listed Staphylococcus sp. as the underlying cause 210 records requested 114 complete records received

Texas Staphylococcal Death Cases in 2005

Texas Staphylococcal Death Cases in 2005

3/26/2009 Response rates to requests for laboratory records by facilities in which staphylococcal deaths occurred in Texas, 2004-2005 Response 2004 1 2005 2 Adequate information 77 (68.2) 114 (51.2) No culture reports 12 (10.6) 40 (17.9) No response 24 (21.2) 69 (30.9) Total 113 (100) 223 (100) Medical records requested on 210 deaths Number ( %) Medical records requested on sample of 197 total deaths

Race/Ethnicity 2004 Race MRSA # (%) MSSA # (%) White † 39 (67.2) # (%) MSSA # (%) White † 39 (67.2) 19 (37.8) Black 5 (71.4) 2 (28.6) Other 8 (66.7) 4 (33.3) † Reference group

Culture sources of staphylococcal infections resulting in death in Texas, 2004-2005 1 2005 2 Blood 53 (68.8) 51 (44.7) Sputum 11 (14.3) 36 (31.6) Bronchial Wash 3 (3.9) 7 (6.1) Respiratory 5 (4.4) Catheter Tip 2 (2.6) 0 (0.0) Skin 1 (1.3) Spinal fluid Wound 10 (8.8) Urine 4 (3.5) Arterial Line 1 (0.9) Not Listed Total 77 (100) 114 (100) Medical records requested on 210 deaths Number ( %) Medical records requested on sample from 197 deaths

Number of deaths per year reporting staphylococcus as a contributing COD

Number of deaths per year reporting staphylococcus as the underlying COD

Staphylococcal species responsible for infections resulting in death in Texas, 2004-2005

Demographic variables associated with deaths due to MRSA compared with deaths due to MSSA 2004 2005 Sex MRSA # (%) MSSA Male † 33 (64.7) 18 (35.3) 50 (80.6) 12 (19.4) Female 19 (73.9) 7 33 (73.3) 12 (26.7) † Reference group

Demographic variables associated with deaths due to MRSA compared with deaths due to MSSA 2004 2005 Age MRSA # (%) MSSA Mean Age 61 59 69 75 ≥ 30 † 5 (55.6) 4 (44.4) 6 (85.7) 1 (14.3) 31 - 60 16 (69.6) 7 (30.4) 18 3 > 60 31 (68.9) 14 (31.1) (74.7) 20 (25.3) † Reference Group

Association of site of staphylococcal infection with MRSA compared with MSSA

Percent antibiotic resistance of staphylococcal species as reported on susceptibility tests for persons dying of staphylococcal infections in Texas, 2004-2005 *Data are based on hospital laboratory reports. No vancomycin resistant staphylococcus have been confirmed in Texas.

Antibiotic Classification

Percent antibiotic class resistance of staphylococcal species as reported on susceptibility tests for persons dying of staphylococcal infections in Texas, 2004-2005

2005 Texas Population and Staph Death Count

2005 Texas Population and Staph Death Rate (per 100,000)

2005 Texas Population and Staphylococcal Death (Per 100,000)

Staphylococcal Death Count and Rate (per 100,000)

Rural Urban Continuum Code by Staph Death Count

RUC Code and Staph Death Rate (per 100,000)

Staphylococcal Death by Rural-Urban Continuum Code (Per 100,000)

Special Thanks to J. Charles Huber Jr, PhD Asst. Professor of Biostatistics Dept. of Epidemiology and Biostatistics Texas A&M Health Science Center School of Public Health